Target intelligence / Profile preview

FSHD region gene 2 family member J, pseudogene (FRG2JP)

Target: FRG2JP
Molecular classification: Other, Pseudogene

Overview

FSHD region gene 2 family member J, pseudogene (FRG2JP) is classified as a pseudogene in the human genome, with no known protein-coding function or established biological activity. It is part of a gene family associated with the facioscapulohumeral muscular dystrophy (FSHD) region but, as a pseudogene, is not a functional therapeutic target, has no characterized molecular function, and currently shows no direct disease or drug interactions. Its gene locus and designation are documented, but there is no evidence for involvement in cellular processes, drug interaction, or mechanism of action[2][3][4].

Other names: FRG2JPHGNC:51796NCBI Gene:101059926Ensembl:ENSG00000259897

Disease associations

Other

Beyond the preview

Go deeper on FSHD region gene 2 family member J, pseudogene (FRG2JP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FSHD region gene 2 family member J, pseudogene (FRG2JP).

Explore the full profile